Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2023
A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participantsWaasila Jassat, Caroline Mudara, Caroline Vika, et al.
The European Respiratory Journal|October 27, 2018
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimenNorbert Ndjeka, Kathryn Schnippel, Iqbal Master, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance networkRaph L Hamers, Elske Straatsma, Cissy Kityo, et al.
The Lancet. Infectious Diseases|February 15, 2021
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trialKelly E Dooley, Susan L Rosenkranz, Francesca Conradie, et al.
The European Respiratory Journal|December 10, 2015
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosisAlexander S Pym, Andreas H Diacon, Shen-Jie Tang, et al.
The New England Journal of Medicine|March 5, 2020
Treatment of Highly Drug-Resistant Pulmonary TuberculosisFrancesca Conradie, Andreas H Diacon, Nosipho Ngubane, et al.
AIDS (London, England)|October 4, 2018
Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic optionsJean Botha, Francesca Conradie, Harriet Etheredge, et al.
The Lancet. Microbe|July 29, 2024
Bedaquiline: what might the future hold?Emily S Shaw, Neil G Stoker, Jessica L Potter, et al.
Pageof 7